Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-9-6
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1626; author reply 1628
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11547768-Antiviral Agents, pubmed-meshheading:11547768-Cytomegalovirus, pubmed-meshheading:11547768-Cytomegalovirus Infections, pubmed-meshheading:11547768-Cytosine, pubmed-meshheading:11547768-Drug Resistance, Microbial, pubmed-meshheading:11547768-Drug Therapy, Combination, pubmed-meshheading:11547768-Foscarnet, pubmed-meshheading:11547768-Ganciclovir, pubmed-meshheading:11547768-Hematologic Neoplasms, pubmed-meshheading:11547768-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:11547768-Humans, pubmed-meshheading:11547768-Myelodysplastic Syndromes, pubmed-meshheading:11547768-Organophosphorus Compounds, pubmed-meshheading:11547768-Phosphonic Acids, pubmed-meshheading:11547768-Prospective Studies, pubmed-meshheading:11547768-Transplantation, Homologous, pubmed-meshheading:11547768-Treatment Failure, pubmed-meshheading:11547768-Viremia, pubmed-meshheading:11547768-Virus Activation
pubmed:year
2001
pubmed:articleTitle
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
pubmed:publicationType
Letter, Clinical Trial, Comparative Study, Comment